Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tigger transposable element-derived protein 4 (TIGD4) is a human protein encoded by the TIGD4 gene, belonging to the tigger subfamily of the pogo superfamily of DNA-mediated transposons. TIGD4 proteins are evolutionarily related to DNA transposons, including Tc1 and mariner transposases, and share similarities with mammalian centromere protein B. TIGD4 is annotated to have nucleic acid and chromatin binding functions, but its precise biological role is not established. It is not currently considered a therapeutic target, nor are there drugs, mechanisms, or safety issues associated with its modulation. Gene expression data suggest low tissue specificity and a lack of verified disease mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tigger transposable element-derived protein 4 (TIGD4).